FMI Anti-Obesity Therapeutics Market Forecast and Segm | Page 4

Anti-Obesity Therapeutics Market
Impact of Existing and Emerging Anti-Obesity Therapeutics Market Trends And Forecast 2017-2027
Obesity is a condition of being very fat and overweight. Anti-obesity therapeutics are referred as the
treatment that reduces and control the body weight. The obesity is rising due to the lack of physical
activities, improper or lack of sleep, high calorie diet, and fast food and heredity history of the person.
The ideal anti-obesity therapeutics follows mechanisms that regulate energy balance which have
substantial built-in-redundancy and overlap with other physiological functions of the body.
In the past decade, numerous anti-obesity therapeutic drugs approved such as Knoll and Acomplia
(rimonabant) and few drugs are also removed from the market due to its side effects such as
cardiovascular diseases, depression and psychological disorders.
In the current lifestyle, being slim and fit has become the trend. The rising concern of being overweight
and obese resulted in the risk of many chronic diseases, cardiovascular diseases and cancer, leads to the
need of cure and prevention of obesity which augments the market growth of the anti-obesity
therapeutics.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3205
Anti-Obesity Therapeutics Market: Drivers and Restraints
The global anti-obesity therapeutics market is projected to grow at a significant CAGR over a forecast
©2015 Future Market Insights, All Rights Reserved
4